[go: up one dir, main page]

YU34804A - Organoleptički prihvatljivi preparati sa oralnim razlaganjem - Google Patents

Organoleptički prihvatljivi preparati sa oralnim razlaganjem

Info

Publication number
YU34804A
YU34804A YU34804A YUP34804A YU34804A YU 34804 A YU34804 A YU 34804A YU 34804 A YU34804 A YU 34804A YU P34804 A YUP34804 A YU P34804A YU 34804 A YU34804 A YU 34804A
Authority
YU
Yugoslavia
Prior art keywords
organoleptically acceptable
disintegrating compositions
intraorally disintegrating
compositions
intraorally
Prior art date
Application number
YU34804A
Other languages
English (en)
Inventor
Trang Le
Blake Ludwig
Joseph Reo
Uday Shah
Ken Yamamoto
Original Assignee
Pharmacia Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corporation filed Critical Pharmacia Corporation
Publication of YU34804A publication Critical patent/YU34804A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Opisane su brzo-otapajuće tablete sa oralnim razlaganjem i procesi za njihovo dobijanje. Preparati su korisni za lečenje ili profilaksu velikog broja oboljenja ili stanja.[Orally disintegrating fast-melt tablets and processes for preparing such dosage forms are provided. The compositions are useful in treatment or prophylaxis of a wide range of conditions and disorders.
YU34804A 2001-09-26 2002-09-23 Organoleptički prihvatljivi preparati sa oralnim razlaganjem YU34804A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32535601P 2001-09-26 2001-09-26

Publications (1)

Publication Number Publication Date
YU34804A true YU34804A (sh) 2006-08-17

Family

ID=23267542

Family Applications (1)

Application Number Title Priority Date Filing Date
YU34804A YU34804A (sh) 2001-09-26 2002-09-23 Organoleptički prihvatljivi preparati sa oralnim razlaganjem

Country Status (25)

Country Link
US (1) US20030181501A1 (sh)
EP (2) EP1490035A1 (sh)
JP (2) JP2005506987A (sh)
KR (2) KR20040044990A (sh)
CN (2) CN1703203A (sh)
AP (2) AP2004002998A0 (sh)
AR (1) AR037239A1 (sh)
BR (2) BR0212861A (sh)
CA (2) CA2461044A1 (sh)
CO (2) CO5570659A2 (sh)
EA (2) EA200400357A1 (sh)
EC (1) ECSP045029A (sh)
GE (1) GEP20063856B (sh)
HK (1) HK1079988A1 (sh)
IL (2) IL160848A0 (sh)
IS (2) IS7177A (sh)
MA (2) MA27542A1 (sh)
MX (2) MXPA04002798A (sh)
NO (2) NO20041258L (sh)
OA (2) OA13060A (sh)
PL (2) PL369298A1 (sh)
TN (2) TNSN04045A1 (sh)
WO (2) WO2003026623A1 (sh)
YU (1) YU34804A (sh)
ZA (2) ZA200401953B (sh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005002557A1 (en) * 2003-07-03 2005-01-13 Warner-Lambert Company Llc Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof
US20050186271A1 (en) * 2004-02-24 2005-08-25 Sheskey Paul J. Process for dispersing a fluid in a mass of solid particles
KR20130018956A (ko) * 2004-08-10 2013-02-25 아지노모토 가부시키가이샤 쓴맛이 감소된 나테글리니드 함유 제제
US20080063710A1 (en) * 2004-12-28 2008-03-13 Eisai R&D Management Co., Ltd. Rapidly Disintegrating Tablet and Production Method Thereof
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN101340899A (zh) * 2005-12-20 2009-01-07 卫材R&D管理有限公司 含有脂溶性药物的口腔内速崩片
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US20090136570A1 (en) * 2006-01-20 2009-05-28 Bhagwant Rege Taste-Masked Tablets and Granules
US20070196494A1 (en) * 2006-02-17 2007-08-23 Arnaud Grenier Low-friability, patient-friendly orally disintegrating formulations
EP2026792A2 (en) * 2006-05-19 2009-02-25 Somaxon Pharmaceuticals, Inc. Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
EP2164461B1 (de) * 2007-06-06 2013-01-23 Basf Se Kau- und lutsch-tabletten
CN102046147B (zh) * 2007-06-06 2013-03-20 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制剂
ES2646112T3 (es) * 2007-06-06 2017-12-12 Basf Se Formulación farmacéutica para la fabricación de comprimidos que se desintegran rápidamente
CN101707930B (zh) * 2007-06-06 2013-10-30 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制剂
KR101606944B1 (ko) * 2007-08-07 2016-03-28 아셀알엑스 파마슈티컬스 인코퍼레이티드 경구 경점막 투여형을 사용한 시술시 진정과 무통을 위한 조성물 및 방법
WO2009118589A2 (en) 2008-03-24 2009-10-01 Wockhardt Research Centre Orally disintegrating compositions of rhein or diacerein
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
WO2010061846A1 (ja) * 2008-11-25 2010-06-03 田辺三菱製薬株式会社 口腔内速崩壊性錠及びその製造方法
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
CN106822007B (zh) 2015-09-11 2021-12-31 西姆莱斯股份公司 口服制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
IN182040B (sh) * 1995-06-13 1998-12-12 American Home Prod
PT855988E (pt) * 1995-10-20 2002-10-31 Upjohn Co Embalagem de bolhas
JPH11512754A (ja) * 1996-05-17 1999-11-02 メルク エンド カンパニー インコーポレーテッド シクロオキシゲナーゼ―２媒介疾患の一日一回治療用組成物
EP0863134A1 (en) * 1997-03-07 1998-09-09 Merck Frosst Canada Inc. 2-(3,5-difluorophenyl)-3-(4-(methyl-sulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cyclooxygenase-2
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
BR0008059A (pt) * 1999-12-08 2002-03-26 Pharmacia Corp Composições de valdecoxib
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
US6800297B2 (en) * 2000-06-15 2004-10-05 Acusphere, Inc. Porous COX-2 inhibitor matrices and methods of manufacture thereof
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
AU2001285011A1 (en) * 2000-08-18 2002-03-04 Pharmacia Corporation Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor

Also Published As

Publication number Publication date
TNSN04045A1 (fr) 2006-06-01
OA13060A (en) 2006-11-10
BR0212778A (pt) 2004-12-07
CO5570659A2 (es) 2005-10-31
WO2003026623A8 (en) 2004-09-30
EP1490035A1 (en) 2004-12-29
WO2003026697A2 (en) 2003-04-03
AP2004002998A0 (en) 2004-03-31
PL369298A1 (en) 2005-04-18
IL160855A0 (en) 2004-08-31
EA200400357A1 (ru) 2004-08-26
EP1429736A2 (en) 2004-06-23
MA27542A1 (fr) 2005-10-03
GEP20063856B (en) 2006-06-26
MA27682A1 (fr) 2006-01-02
MXPA04002798A (es) 2004-07-05
JP2005506987A (ja) 2005-03-10
NO20041258L (no) 2003-03-27
CA2461630A1 (en) 2003-04-03
KR20040044990A (ko) 2004-05-31
HK1079988A1 (zh) 2006-04-21
IL160848A0 (en) 2004-08-31
NO20041532L (no) 2004-04-15
CO5570684A2 (es) 2005-10-31
KR20040058189A (ko) 2004-07-03
WO2003026623A1 (en) 2003-04-03
MXPA04002652A (es) 2004-06-07
PL369297A1 (en) 2005-04-18
CN1703203A (zh) 2005-11-30
IS7177A (is) 2004-03-11
EA200400352A1 (ru) 2004-12-30
JP2005512964A (ja) 2005-05-12
OA12707A (en) 2006-06-26
BR0212861A (pt) 2004-10-05
TNSN04047A1 (fr) 2006-06-01
US20030181501A1 (en) 2003-09-25
AP2004002999A0 (en) 2004-03-31
ECSP045029A (es) 2004-04-28
ZA200401953B (en) 2005-05-09
AR037239A1 (es) 2004-11-03
IS7178A (is) 2004-03-11
ZA200402364B (en) 2005-01-13
CA2461044A1 (en) 2003-04-03
WO2003026697A3 (en) 2003-07-03
CN1633281A (zh) 2005-06-29

Similar Documents

Publication Publication Date Title
AP2004002999A0 (en) Organoleptically acceptable intraorally disintegrating compositions
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
MXPA03007613A (es) Composiciones y metodos de fabricacion para formas de dosis oral disolubles.
TWI265808B (en) Valdecoxib compositions
MXPA03010549A (es) Formas de dosificacion de oxcarbazepina.
AP1637A (en) Celecoxib compositions.
AU2003297048A8 (en) Cyclohexyl compounds as ccr5 antagonists
AU2003296992A1 (en) Pyrrolidine and azetidine compounds as ccr5 antagonists
WO2004054974A3 (en) Piperidine derivatives as ccr5 antagonists
MXPA02006151A (es) Composiciones de liberacion dual de un inhibidor de ciclooxigenasa-2.
MY130727A (en) Controlled-release pharmaceutical formulations
AU2003296993A8 (en) Cyclopropyl compounds as ccr5 antagonists
AU2002255321A1 (en) Tablets quickly disintegrating in the oral cavity and process for producing the same
AU2002255321A2 (en) Tablets quickly disintegrating in the oral cavity and process for producing the same
ZA200409894B (en) Orally disintegrating tablets and process for obtaining them
PL363679A1 (en) Novel use of 2-phenyl-substituted imidazotriazinones
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
YU37104A (sh) Preparati valdekoksiba sa oralnim razlaganjem dobijeni postupkom sušenja raspršivanjem
DE60212130D1 (en) Carvedilolpolymorph
MXPA04004290A (es) Composiciones de valdecoxib que se disgregan intraoralmente preparadas mediante un procedimiento de granulacion en lecho fluido.
PL359727A1 (en) Crystalline pharmaceutical
MXPA01009032A (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso se la produccion de il-12.
MD2228F1 (en) Use of isothiouronic derivatives in the treatment and prophylaxis of intestinal atony
WO2005051489A3 (en) Fast dissolving solid oral dosage forms of galanthamine
MD1938B1 (ro) Remediu pentru tratamentul afectiunilor parodontiului si mucoasei cavitatii bucale